Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Dummer
R
R
Department of Dermatology, Zürich University Hospital, Switzerland.
Hauschild
A
A
Guggenheim
M
M
Jost
L
L
Pentheroudakis
G
G
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D054697:Cytostatic Agents / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D016898:Interferon-alpha / Q000627:therapeutic use; D008545:Melanoma / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis / Q000628:therapy; D009367:Neoplasm Staging; D011878:Radiotherapy; D016032:Randomized Controlled Trials as Topic; D009418:S100 Proteins / Q000097:blood; D055502:Secondary Prevention; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
D054697:Cytostatic Agents; D016898:Interferon-alpha; D009418:S100 Proteins